3 hours Why Amgen’s Weight Loss Result Is a Win for Eli LillyThe Motley Fool
Shares of Amgen (NASDAQ: AMGN) recently ticked lower despite a very positive-sounding press release regarding its weight management candidate. According to the giant drugmaker, treatment with an anti-obesity candidate called MariTide helped patients re…
Amgen (AMGN) · Eli Lilly (LLY) · Nasdaq 100
X